Zydus Wellness Ltd

On 26-Nov, Zydus Wellness Ltd witnessed a decline in its share price, closing at ₹435.20, down ₹5.95 or 1.35% from the previous session. This drop reflects a continuation of recent negative trends amid disappointing quarterly earnings and subdued investor participation.

As of November 6, 2025, Zydus Wellness is considered overvalued with a valuation grade of expensive, reflected by a PE ratio of 49.20 and a recent 1-week decline of 8.76%, despite a strong year-to-date return of 14.50%.

Zydus Wellness has shown consistent growth in net sales and profits from March 2020 to March 2025, with net sales increasing from 1,766.82 Cr to 2,708.90 Cr and operating profit peaking at 393.30 Cr, despite some fluctuations in profit margins and cash flow. Total liabilities rose to 6,297.20 Cr, while cash flow from operations improved to 380.00 Cr.

Zydus Wellness reported a net loss of -₹52.80 crores in Q2 FY26, marking its first quarterly loss and a significant decline in profitability, despite a year-on-year revenue growth of 31.97%. The company faces severe operational challenges, with sharply reduced margins and rising costs, making its latest results concerning.

As of 04-Nov, Zydus Wellness Ltd's stock price is Rs 463.25, down 3.32%, with a recent decline of 6.37% over the past week. Despite short-term volatility, the stock has a year-to-date increase of 19.26%, indicating strong long-term performance.

As of November 3, 2025, the trend is mildly bullish with daily moving averages supporting this view, but mixed signals from the MACD and KST suggest a cautious approach.

As of 23-Oct, Zydus Wellness Ltd's stock price is 489.80, reflecting a slight increase and a total return of 6.35% over the last three days. The company has outperformed the market with a 32.55% return over the past year, supported by strong financial metrics and positive operational results, despite a decline in investor participation.

As of October 8, 2025, the trend is bullish with strong support from MACD and moving averages, though caution is advised due to mixed signals from KST and Dow Theory.

As of October 1, 2025, Zydus Wellness shows a mildly bullish trend supported by bullish MACD and moving averages, though mixed signals from the KST and Dow Theory indicate some caution.

As of 30-Sep, Zydus Wellness Ltd's stock price has declined to Rs 459.50, down 5.37%, after two days of gains, with a significant drop in delivery volume. Despite a strong monthly return of 14.16% and outperforming the benchmark over the past year, recent performance has been negatively affected by market dynamics and reduced investor participation.

As of September 29, 2025, Zydus Wellness is fairly valued with a PE ratio of 47.22, outperforming peers like Hindustan Unilever and Nestle India, and showing a year-to-date return of 23.00%, though it has a low dividend yield of 0.25% and modest ROE and ROCE at 6.02% and 6.11%, respectively.

As of September 26, 2025, Zydus Wellness is considered overvalued with a PE ratio of 47.60, despite outperforming the Sensex with a 23.97% year-to-date return, indicating that its high valuation is not justified by its financial metrics compared to peers like Hindustan Unilever and Nestle India.

As of September 26, 2025, Zydus Wellness is overvalued with a PE ratio of 47.60 and low ROCE and ROE, indicating its current price of 481.55 is excessive compared to its peers despite a strong YTD return.